Onyx Pharmaceuticals Out-Licenses Japanese Rights to Proteasome Inhibitors
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 8 (Table of Contents)
Published: 18 Oct-2010
DOI: 10.3833/pdr.v2010.i8.1387 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In its second oncology deal in September 2010, Ono Pharmaceutical has licensed the Japanese rights to two promising protease inhibitors for multiple myeloma, one of which is at the NDA stage, from Onyx Pharmaceuticals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS